
Giotrif, also known by its generic name Afatinib, is a targeted therapy medication primarily used for the treatment of non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGFR) gene.
USD $688.36
Giotrif is a other supplied in 1 unit. Use only under medical supervision.